← Open Payments lookup

ALISON REGAN: Open Payments

NPI 1780425512 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$557 in 27 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $166 · 2025 $557

Food & beverage: $557
CompanyPaymentsAmount
ABBVIE INC.14$253
Astellas Pharma US Inc4$131
Novo Nordisk Inc2$38
Seqirus USA Inc1$25
Otsuka America Pharmaceutical, Inc.1$22
Merck Sharp & Dohme LLC1$22
PFIZER INC.1$20
Exact Sciences Corporation1$17
E.R. Squibb & Sons, L.L.C.1$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14

Products named: Veozah, QULIPTA, VRAYLAR, UBRELVY, ELIQUIS, Flucelvax, REXULTI, GARDASIL 9.

Industry payments across NE — which companies pay providers there.